Angela Walsh | executive |
Greg Duncan | executive |
David Bautz | analyst |
Good morning, and welcome to the Virios Therapeutics, Inc.
First Quarter 2024 Earnings Call.
[Operator Instructions] Please be advised that today's call is being recorded at the company's request. At this time, I'd like to turn the call over to Angela Walsh, Senior Vice President of Finance and Treasurer for Virios Therapeutics. Please proceed, Angela.